All the news Showing 10 of 284 articles from: Access to medicines & diagnosticsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources New Health Ministry Of Chile Reaffirms Path To Compulsory Licence For Hepatitis C Drugs Intellectual Property Watch / 06 September 2018 High Cost of Hepatitis C Drugs Leads to Lengthy Battles for Access to Therapies MD Magazine / 04 September 2018 South Africa: Almost half of injecting drug users surveyed have contracted Hepatitis C Bhekisisa / 15 August 2018 China Patent Challenge Compels Gilead to Withdraw Key Patent Claims on Sofosbuvir Base Compound, Opening Life-Saving Hepatitis C Treatment Access for Millions i-MAK / 10 August 2018 India launches Viral Hepatitis Control Program as domestic drugmakers challenge patents Pharma Letter / 30 July 2018 Fighting hepatitis C demands more than cheap drugs SciDev.Net / 30 July 2018 AbbVie Hepatitis C Treatment Patents Challenged In India For Evergreening Intellectual Property Watch / 27 July 2018 France: people who inject drugs often given cheaper, less effective, hepatitis C medication Manual Items / 17 July 2018 How Big Pharma Was Captured by the One Percent New Republic / 02 July 2018 Private Payers Deny Hepatitis C Drug Coverage to 52% of Members Health Payer Intelligence / 14 June 2018 ← Prev1...23456...29Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive